Literature DB >> 4284528

Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells.

H O Sjögren, I Hellström.   

Abstract

Entities:  

Mesh:

Year:  1965        PMID: 4284528     DOI: 10.1016/0014-4827(65)90319-8

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


× No keyword cloud information.
  15 in total

1.  [Immunological properties of Graffi virus-induced leukemias of the AKR mouse strain].

Authors:  G Pasternak; F Fey; L Pasternak; B Hölzer
Journal:  Z Krebsforsch       Date:  1967

Review 2.  Immunological studies on Burkitt's lymphoma.

Authors:  G Klein
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

3.  Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.

Authors:  R R Salup; R H Wiltrout
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.

Authors:  S R Zhang; R R Salup; P E Urias; T A Twilley; J E Talmadge; R B Herberman; R H Wiltrout
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.

Authors:  J J Mulé; S L Schwarz; A B Roberts; M B Sporn; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.

Authors:  R H Wiltrout; E Gorelik; M J Brunda; H T Holden; R B Herberman
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.

Authors:  Nidia Alvarez-Rueda; Ariane Desselle; Denis Cochonneau; Tanguy Chaumette; Béatrice Clemenceau; Stéphanie Leprieur; Gwenola Bougras; Stéphane Supiot; Jean-Marie Mussini; Jacques Barbet; Julie Saba; François Paris; Jacques Aubry; Stéphane Birklé
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

8.  Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.

Authors:  N L Vujanovic; R B Herberman; A A Maghazachi; J C Hiserodt
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

9.  Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.

Authors:  R H Wiltrout; B J Mathieson; J E Talmadge; C W Reynolds; S R Zhang; R B Herberman; J R Ortaldo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

10.  In vitro demonstration of humoral and cell-bound immunity against common specific transplantation atigen(s) of adenovirus 12-induced mouse and hamster tumors.

Authors:  I Hellström; H O Sjögren
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.